Tigecycline inhibits proliferation of Acanthamoeba castellanii.

Parasitol Res 2015 Mar 7;114(3):1189-95. Epub 2015 Jan 7.

Department of Microbiology, Keimyung University School of Medicine, 1095 Dalgubeol-daero, Dalseo-gu, Daegu, 704-701, Republic of Korea.

Acanthamoeba is an opportunistic protozoan parasite responsible for different diseases in humans, such as granulomatous amoebic encephalitis and amoebic keratitis. Tigecycline, a third-generation tetracycline antibiotic, has potential activity to treat most of the antibiotic resistant bacterial infections. The effects of tigecycline in eukaryotic cells as well as parasites are less well studied. In the present study, we tested the effects of tigecycline on trophozoites of Acanthamoeba castellanii. The inhibitory effect of tigecycline on Acanthamoeba was determined by resazurin reduction and trypan blue exclusion assays. We found that tigecycline significantly inhibited the growth of Acanthamoeba (46.4 % inhibition at the concentration of 100 μM) without affecting cell viability and induction of encystation, whereas other tetracycline groups of antibiotics such as tetracycline and doxycycline showed no inhibitory effects. Furthermore, tigecycline decreased cellular adenosine triphosphate (ATP) level by 26 % than the control and increased mitochondrial mass, suggesting mitochondrial dysfunction in tigecycline-treated cells. These findings suggest that mitochondrial dysfunction with decreased ATP production might play an important mechanism of tigecycline in suppression of Acanthamoeba proliferation.

Download full-text PDF

http://dx.doi.org/10.1007/s00436-014-4302-1DOI Listing
March 2015

Publication Analysis

Top Keywords

effects tigecycline
acanthamoeba castellanii
mitochondrial dysfunction
acanthamoeba 464
464 inhibition
growth acanthamoeba
inhibited growth
tigecycline inhibited
inhibition concentration
concentration 100
induction encystation
encystation tetracycline
viability induction
cell viability
100 μm
μm cell
assays tigecycline
exclusion assays

Similar Publications

In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.

Parasitol Res 2013 Dec 12;112(12):4087-95. Epub 2013 Sep 12.

Department of Biomedicine and Biotechnology, School of Pharmacy, University of Alcalá, Ctra. Madrid-Barcelona (Autovía A2) Km. 33 600, 28871, Alcalá de Henares, Madrid, Spain.

The species of the genus Acanthamoeba are opportunistic protozoan parasites that cause different diseases in humans, such as amoebic keratitis and granulomatous encephalitis. The rise in the rate of Acanthamoeba keratitis, mainly due to the increase in contact lens wearers, turns the development of viability assays using a multi-well plate reader as a tool for screening new antiamoebic agents in vitro into an important goal. In our study, the viability assays PrestoBlue®, resazurin sodium salt, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) and CellTiter96® were tested for their suitability as time-saving alternatives to the classical manual or direct-counting method, assessing the effect of the antiamoebic agent chlorhexidine digluconate and temperature on Acanthamoeba castellanii (ATCC® 30234™) and Acanthamoeba polyphaga 2961. Read More

View Article and Full-Text PDF
December 2013

Apoptosis of Acanthamoeba castellanii Trophozoites Induced by Oleic Acid.

J Eukaryot Microbiol 2018 03 28;65(2):191-199. Epub 2017 Aug 28.

Department of Medical Microbiology and Parasitology, Fudan University School of Medicine, Shanghai, 200032, China.

Acanthamoeba spp. can be parasitic in certain situations and are responsible for serious human infections, including Acanthamoeba keratitis, granulomatous amoebic encephalitis, and cutaneous acanthamoebiasis. We analyzed the fatty acid composition of Acanthamoeba castellanii trophozoites and tested the inhibitory activity of the main fatty acids, oleic acid and arachidonic acid, in vitro. Read More

View Article and Full-Text PDF
March 2018

Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.

Exp Parasitol 2020 Aug 24;215:107915. Epub 2020 May 24.

Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, Sharjah, 26666, United Arab Emirates.

Acanthamoeba castellanii is an opportunistic protozoan responsible for serious human infections including Acanthamoeba keratitis and granulomatous amoebic encephalitis. Despite advances in antimicrobial therapy and supportive care, infections due to Acanthamoeba are a major public concern. Current methods of treatment are not fully effective against both the trophozoite and cyst forms of A. Read More

View Article and Full-Text PDF
August 2020

In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.

Antimicrob Agents Chemother 2013 Aug 13;57(8):3561-7. Epub 2013 May 13.

Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.

The effects of clinically available drugs targeting muscarinic cholinergic, adrenergic, dopaminergic, and serotonergic receptors; intracellular calcium levels and/or the function of calcium-dependent biochemical pathways; ion channels; and cellular pumps were tested against a keratitis isolate of Acanthamoeba castellanii belonging to the T4 genotype. In vitro growth inhibition (amoebistatic) assays were performed by incubating A. castellanii with various concentrations of drugs in the growth medium for 48 h at 30°C. Read More

View Article and Full-Text PDF
August 2013